1. Once-daily gentamicin: translating theory into practice

   • R. Cunningham
   • H. Humphreys

   SPECIAL ARTICLE Pages: 151 - 154

2. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients

   • I. Kantola
   • A. Terént
   • M. Kataja

   CLINICAL TRIALS Pages: 155 - 159

3. Is overuse of sumatriptan a problem? A population-based study

   • D. Gaist
   • J. Hallas
   • L. F. Gram

   PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 161 - 165

4. Ketotifen in HIV-infected patients: effects on body weight and release of TNF-α

   • J. Ockenga
   • F. Rohde
   • I. Schedel

   PHARMACODYNAMICS Pages: 167 - 170

5. Comparison of dose requirement, serum erythropoietin and blood pressure following intravenous and subcutaneous erythropoietin treatment of dialysis patients IV and SC erythropoietin

   • J. D. Jensen
   • J. K. Madsen
   • L. W. Jensen

   PHARMACODYNAMICS Pages: 171 - 177

6. Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle

   • S. E. Møller
   • B. Maach-Møller
   • B. Fjalland

   PHARMACODYNAMICS Pages: 179 - 184

7. Are there stereoselective electrophysiologic effects of intravenously administered (S)- or (R)-propafenone hydrochloride in patients with supraventricular tachycardia?

   • R. Candinas
   • H. O. Gloor
   • F. Follath

   PHARMACODYNAMICS Pages: 185 - 190

8. Adverse events with continuous doxapram infusion against late postoperative hypoxaemia

   • J. Rosenberg
   • P. A. Kristensen
   • H. Overgaard

   PHARMACODYNAMICS Pages: 191 - 194

9. Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C- and 12C-nifedipine

   • H. Bode
   • E. Brendel
   • A. H. Staib

   PHARMACOKINETICS AND DISPOSITION Pages: 195 - 201

10. Pharmacokinetic interaction between cyclosporine and the dihydropyridine calcium antagonist felodipine

    • J. K. Madsen
    • J. D. Jensen
    • E. B. Pedersen

    PHARMACOKINETICS AND DISPOSITION Pages: 203 - 208

11. In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

    • C. Transon
    • T. Leemann
    • P. Dayer

    PHARMACOKINETICS AND DISPOSITION Pages: 209 - 215

12. Intraindividual variability in red blood cell thiopurine methyltransferase activity

    • T. Giverhaug
    • B. Klemetsdal
    • J. Aarbakke

    PHARMACOKINETICS AND DISPOSITION Pages: 217 - 220

13. Effect of food on the bioavailability of oxybutynin from a controlled release tablet

    • E. Lukkari
    • P. Castrèn-Kortekangas
    • P. J. Neuvonen

    PHARMACOKINETICS AND DISPOSITION Pages: 221 - 223

14. Metabolic and analytical interactions of grapefruit juice and 1,2-benzopyrone (coumarin) in man

    • M. Runkel
    • M. Tegtmeier
    • W. Legrum

    PHARMACODYNAMICS Pages: 225 - 230

15. Influence of repeated oral doses of ethinyloestradiol on the metabolic disposition of [13C2]-ethinyloestradiol in young women

    • W. Kuhnz
    • M. Hümpel
    • D. Gross

    PHARMACOKINETICS AND DISPOSITION Pages: 231 - 235

16. Effect of physical activity on serum concentrations of digoxin and digitoxin

    • W. Grille
    • U. Welter
    • H. Löffler

    PHARMACOKINETICA AND DISPOSITION Pages: 237 - 239

17. Stereoselective pharmacokinetics of mefloquine in young children

    • A. Bourahla
    • C. Martin
    • R. Farinotti

    PHARMACOKINETICS AND DISPOSITION Pages: 241 - 244

18. Concept of bridging studies and ethical concerns

    • H. J. Koch

    LETTER TO THE EDITORS Pages: 245 - 246